Jose Nieto, DO
Gastroenterology · Sebring, FLNPI 1225190002
Payments from drug & device makers
Across 593 payments — averaging $966.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$314K
- Boston Scientific$198K
- Conmed Corporation$18K
- US Endoscopy$15K
- Olympus Corporation Of The Americas$12K
- ERBE USA Inc$10K
- plus $7K from 37 others
What the payments were for
- Consulting fees$59,01310%
- Speaking & faculty fees$438,14376%
- Travel & lodging$64,51511%
- Food & beverage$11,5312%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Creon$187,420
- ACQUIRE$56,538
- AXIOS$41,343
- GENERAL - THERAPIES$30,222
- ORISE$23,095
- CONMED GASTROSTOMY$11,575
- Resolution 360 Clip$10,316
- ERBE$9,500
- Resolution 360 ULTRA Clip$9,289
- RESOLUTION CLIP$5,950
- Single Use Repositionable Clip$3,998
- SPYGLASS$3,050
- EXPECT$2,890
- CONMED HEMOSTASIS$2,678
- Single Use Electrosurgical Knife KD-655$867
- LINVATEC ENDOSCOPES AND SHEATHS$600
- Creo Medical$199
- GI Genius$180
- Olympus EMR & ESD Devices$135
- REZDIFFRA$133
How this compares
$573,300 in reported general payments places this provider in the 95th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 26 | $27,767 |
| LinzessLinaclotide | 18 | $17,187 |
| Omeprazole | 16 | $300 |
| Sucralfate | 13 | $204 |
| Pantoprazole Sodium | 27 | $201 |
| Metoclopramide Hcl | 16 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $136 | $27,76726 claims |
| AbbVieLinzess | $313,824 | $17,18718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Sebring
- Howard SchwartzTavernier$38.8M
- Guy NeffSarasota$17.6M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Alan WeintraubTampa$4.7M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
- Henry LevineOrlando$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.